Neuroblastoma, Metastatic
2 clinical trials · Condition
◉ Watch Neuroblastoma, Metastatic
| Record | Firm | Date |
|---|---|---|
| Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers (NCT05296564) | Hadassah Medical Organization | 2022-04-01 |
Track Neuroblastoma, Metastatic automatically
Every clearance here is in the API, with alerts when new ones post.